• COVID-19
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
    • Corporate TB Pledge
    • Urban Health
    • Inclusive Development
  • PHC INNOVATIONS
  • LEARNING LIBRARY
  • DATA VISUALIZATION

This section hosts guidelines, manuals and toolkits to strengthen public health practice.

Resources

FILTER
BY CATEGORY

View All

COVID-19 Stay Tuned Nutrition For implementers For policymakers Report For researchers Research Urban Health M&E

EXPLORE DATA
VISUALIZATIONS

Explore key data on health and its determinants in India through interactive graphs.

NACP V Strategy

23 May 2022
Health System Strengthening

by MohFW OVER 1 HOUR

In 1985, India launched a sero-surveillance program in response to the HIV/AIDS epidemic. The establishment of the National AIDS and STD Control Programme (NACP) in 1992 cemented the commencement of a coherent response to the HIV/AIDS epidemic in India. Earlier efforts (1985-1991) concentrated on searching for HIV in various demographic groups and places, screening blood before transfusion, and targeted awareness generation. Since then, NACP has progressed through five distinct phases to become one of the world's largest HIV programs.

The first phase of NACP focused on raising awareness and ensuring the safety of blood. The second phase saw direct interventions launched across the prevention-detection-treatment continuum, along with State’s capacity for program administration being built. The third phase was a scaling-up tale, with program administration devolved all the way down to the district level. Consolidation and increased government funding marked the fourth phase. The need for continued action and vigilance in the context of the country's resolve to eliminate the AIDS epidemic as a public health issue by 2030 prompted the development of NACP Phase-V.

NACP Phase-V is a Central Sector Scheme with a budget of Rs 15471.94 crore, wholly supported by the Government of India. By 2025-26, the NACP Phase-V intends to cut annual new HIV infections and AIDS-related deaths by 80% compared to the baseline figure of 2010 (47%). While existing interventions will be preserved, refined, and strengthened under NACP Phase-V, innovative techniques will be adopted, piloted, and scaled-up to address geographic and community-specific requirements. NACP Phase-V will build on the systematized convergence with existing Central Government schemes, such as synergy with the National Health Programme, associated line Ministries, and State Governments, by mainstreaming and partnering to broaden the reach of various HIV-related services in a cost-neutral manner. Continued strategic engagement with the business sector is part of the NACP Phase-V collaboration framework.   

In NACP Phase-V, the HIV and AIDS (Prevention and Control) Act of 2017 will remain the pillar of the national response to the HIV and STI epidemic. The Act will serve as the enabling foundation for removing impediments to the delivery of a holistic package of services in a stigma-free environment.

Related File :

9253720613.pdf

Categories

For implementers
KEY ORGANIZATIONS
Connect with Us
Subscribe to the Newsletter

FOLLOW US

  • HOME
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
  • LEARNING LIBRARY
  • DATA VISUALIZATION
  • ABOUT US
  • CONTACT US
  • PRIVACY POLICY
Disclaimer: This website is made possible by the support of the American People through the United States Agency for International Development (USAID). The Learning4impact partnership is supported by USAID/India Health Office, under Cooperative Agreement # 72038618CA00001 with Swasti. The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of USAID, the United States Government, or Swasti.
Copyright 2025 Swasti Health Catalyst

Subscribe to the Newsletter

Submit Feedback

  • COVID-19
  • THEMES
  • USAID INVESTMENTS
  • SPECIAL FOCUS AREAS
    • Corporate TB Pledge
    • Urban Health
    • Inclusive Development
  • PHC INNOVATIONS
  • LEARNING LIBRARY
  • DATA VISUALIZATION